Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1152 studies found for:    glioblastoma multiforme
Show Display Options
Rank Status Study
1 Recruiting Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
Condition: Glioblastoma Multiforme
Intervention: Other: ketogenic diet
2 Completed A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: MEDI-575
3 Terminated Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: TLN-4601
4 Recruiting Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Radiation: Radiochemotherapy
5 Terminated
Has Results
Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Drug: Everolimus;   Procedure: Surgery
6 Recruiting Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention:
7 Terminated
Has Results
TRC105 for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: TRC105
8 Completed Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: XL184
9 Completed
Has Results
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Biological: ICT-107;   Biological: Placebo DC
10 Completed Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.
Condition: Glioblastoma Multiforme
Intervention: Drug: H-1PV
11 Completed A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Radiation: Hypofractionated Intensity-Modulated Radiation Therapy;   Drug: Temozolomide
12 Completed Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
Condition: Recurrent Glioblastoma Multiforme
Interventions: Drug: Panzem NCD;   Drug: Temozolomide
13 Recruiting Neoadjuvant Nivolumab in Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: Nivolumab
14 Withdrawn Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
Condition: Glioblastoma Multiforme
Intervention: Drug: IL-4PE
15 Unknown  Vitamin D for Treatment of Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Other: Surgery;   Radiation: Radiotherapy to tumour bed and/or residual tumour;   Drug: Temozolomide;   Drug: Vitamin D3
16 Completed
Has Results
Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Biological: Autologous Dendritic Cell;   Drug: Temozolomide;   Procedure: Radiotherapy;   Biological: Dendritic Cell Vaccine
17 Not yet recruiting uPAR-PET/MRI in Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: One injection of 68Ga-NOTA-AE105;   Device: PET/MRI
18 Completed Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: Azixa
19 Recruiting Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Biological: anti-EGFRvIII CAR T cells;   Drug: cyclophosphamide;   Drug: Fludarabine
20 Not yet recruiting Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
Condition: Glioblastoma Multiforme (GBM)
Intervention: Drug: Fluciclitite , PET imaging, and Bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.